ASAM Provider Guide

National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1224390

Contents of this Issue

Navigation

Page 14 of 29

15 Common Dosing Advantages Disadvantages Range: 60mg–120mg (daily) Strongest retention in treatment; improved social functioning associated with reductions in criminal activity, recidivism, and infectious disease acquisition and transmission More frequent clinic visits; only SAMHSA-certified OTPs may provide methadone for addiction treatment; higher risk for respiratory depression due to long half-life and stacking effect (requires more monitoring ) Range: 4mg–24mg (daily) Ceiling effects on respiratory depression; more rapid induction to steady state dose; less potential for euphoria (compared to methadone); considered safe for office- based treatment; improved social functioning ; associated with reductions in criminal activity, recidivism, and infectious disease acquisition and transmission Requires X-Waiver to prescribe; risk for overdose when combined with alcohol, benzodiazepines, or other sedatives Range: 4mg/1mg to 24mg/6mg (daily) Range: 2.9mg/0.71mg to 17.2mg/4.2mg (daily) Range: 2.1mg/0.3mg to 12.6mg/2.1mg (daily) Range: 4mg/1mg to 24mg/6mg (daily) (daily)

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update